Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 429 · see citing works

PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

Juhan-Vague, I., & Alessi, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657607 · Cited by 381 · see citing works

Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet

Crosignani, P. G. (2003) · Human Reproduction · doi:10.1093/humrep/deg367 · Cited by 359 · see citing works

Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1

Skurk, T., & Hauner, H. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802778 · Cited by 297 · see citing works

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.

Sappino, A. P., Huarte, J., Belin, D., et al. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.5.2471 · Cited by 283 · see citing works

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

Velázquez-Maldonado, E., Mendoza, S. G., Wang, P., & Glueck, C. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90066-4 · Cited by 249 · see citing works

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

Vanky, E., Salvesen, K., Heimstad, R., Fougner, K., Romundstad, P., & Carlsen, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh347 · Cited by 242 · see citing works

Thrombophilia and pregnancy complications

Kujovich, J. L. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.03.001 · Cited by 240 · see citing works

Polycystic ovaries and recurrent miscarriage—a reappraisal

Rai, R., Backos, M., Rushworth, F., & Regan, L. (2000) · Human Reproduction · doi:10.1093/humrep/15.3.612 · Cited by 215 · see citing works

Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome

Glueck, C. J., Wang, P., Fontaine, R. N., Sieve-Smith, L., Tracy, T., & Moore, S. K. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90250-0 · Cited by 191 · see citing works

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy

Glueck, C. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh109 · Cited by 182 · see citing works

Metformin Administration<i>Versus</i>Laparoscopic Ovarian Diathermy in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome: A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial

Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., et al. (2004) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2004-0689 · Cited by 177 · see citing works

Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome1

Jakubowicz, D. J., Seppälä, M. T., Jakubowicz, S., Rodriguez-Armas, O., Rivas-Santiago, A., Koistinen, H. K., Koistinen, R., & Nestler, J. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7295 · Cited by 164 · see citing works

Impact of Insulin Resistance on Pregnancy Complications and Outcome in Women with Polycystic Ovary Syndrome

Bjercke, S., Dale, P. O., Tanbo, T. G., Storeng, R., Ertzeid, G., & Åbyholm, T. (2002) · Gynecologic and Obstetric Investigation · doi:10.1159/000067719 · Cited by 138 · see citing works

Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome

Jakubowicz, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1126 · Cited by 130 · see citing works

Plasminogen Activator Inhibitor-1

Gils, A., & Declerck, P. J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364595 · Cited by 129 · see citing works

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

Glueck, C. J., Bornovali, S., Pranikoff, J., Goldenberg, N., Dharashivkar, S., & Wang, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01251.x · Cited by 115 · see citing works

Reduced Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein-1 in Women with Polycystic Ovary Syndrome during First Trimester of Pregnancy

Jakubowicz, D. J., Essah, P. A., Seppälä, M. T., Jakubowicz, S., Baillargeon, J., Koistinen, R. A., & Nestler, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030975 · Cited by 84 · see citing works

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

Orio, F., Palomba, S., Cascella, T., Tauchmanovà, L., Nardo, L. G., Biase, S. D., Labella, D., Russo, T., Tolino, A., Zullo, F., et al. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61634-3 · Cited by 72 · see citing works

Should we continue or stop insulin sensitizing drugs during pregnancy?

Norman, R. J., Wang, J. X., & Hague, W. M. (2004) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/00001703-200406000-00007 · Cited by 71 · see citing works

Pregnancy Loss, Polycystic Ovary Syndrome, Thrombophilia, Hypofibrinolysis, Enoxaparin, Metformin

Glueck, C. J., Wang, P., Goldenberg, N., & Sieve, L. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000404 · Cited by 68 · see citing works

Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage

Glueck, C. J., Awadalla, S. G., Phillips, H., Cameron, D., Wang, P., & Fontaine, R. N. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00630-0 · Cited by 56 · see citing works

Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss

Glueck, C. J., Wang, P., Bornovali, S., et al. (2003) · Metabolism · doi:10.1016/j.metabol.2003.06.001 · Cited by 53 · see citing works

Plasminogen Activator Inhibitor‐1: Physiologic Role, Regulation, and the Influence of Common Pharmacologic Agents

Tsikouris, J. P., Suarez, J. A., & Meyerrose, G. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002762491271 · Cited by 49 · see citing works

Gene regulation of interleukin-1β, interleukin-1 receptor type I, and plasminogen activator inhibitor-1 and -2 in human granulosa-luteal cells

Piquette, G. N., Simón, C., Danasouri, I. E., et al. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57001-0 · Cited by 46 · see citing works

Metformin, but not Thiazolidinediones, Inhibits Plasminogen Activator Inhibitor-1 Production in Human Adipose Tissuein Vitro

He, G., Pedersen, S. B., Bruun, J. M., Lihn, A. S., & Richelsen, B. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-38386 · Cited by 43 · see citing works

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

Palomba, S., Orio, F., Russo, T., Falbo, A. I., Cascella, T., Colao, A. A. L., Lombardi, G., & Zullo, F. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347527 · Cited by 29 · see citing works

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: A comprehensive review

Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426 · see citing works

Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline

Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379 · see citing works

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis

Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143 · see citing works

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei351 · Cited by 85 · see citing works

A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage

Cocksedge, K. A., Li, T.-C., Saravelos, S. H., & Metwally, M. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60304-5 · Cited by 73 · see citing works

Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis

Tan, X., Li, S., Chang, Y., Fang, C., Liu, H., Zhang, X., & Wang, Y. (2016) · Clinical and Investigative Medicine · doi:10.25011/cim.v39i4.27091 · Cited by 51 · see citing works

당뇨를 동반한 4기 대장암 환자에서 항암약물요법 반응 및 생존율에 대한 Metformin의 효과

이동준, 김번, 이진하, et al. (2012)

Metformin for Prevention of Type 2 Diabetes

Hess, A. M., & Sullivan, D. L. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d537 · Cited by 11 · see citing works

A Rare Side Effect of Metformin: Metformin-Induced Hepatotoxicity

Aksay, E. (2007) · DergiPark (Istanbul University) · Cited by 15 · see citing works

Metformin-induced mitochondrial Complex I inhibition: facts, uncertainties, and consequences

Fontaine, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00753 · Cited by 269 · see citing works

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 246 · see citing works